Laying the foundation for Real-world evidence studies: a case study from Newfoundland and Labrador

The Janssen and Newfoundland and Labrador Health Innovation Partnership (JANL-HIP) was established to carry out Real-World Evidence (RWE) projects to generate evidence about disease pathways, healthcare delivery, the effects of clinical interventions. Doing so will support and influence clinical dec...

Full description

Bibliographic Details
Published in:International Journal of Population Data Science
Main Authors: Badaiki, Winifred, Pyper, Evelyn, Lester, Kendra, Skeard, Janelle, Penney, Michelle, Shin, Janey, Fisher, Brenda, Hew, Huong, Gulliver, Susanne, Gulliver, Wayne, Rahman, Proton
Format: Text
Language:English
Published: Swansea University 2022
Subjects:
Population Data Science
Newfoundland
Online Access:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464867/
http://www.ncbi.nlm.nih.gov/pubmed/37650031
https://doi.org/10.23889/ijpds.v7i1.1690
Description
Summary:The Janssen and Newfoundland and Labrador Health Innovation Partnership (JANL-HIP) was established to carry out Real-World Evidence (RWE) projects to generate evidence about disease pathways, healthcare delivery, the effects of clinical interventions. Doing so will support and influence clinical decision-making in Newfoundland and Labrador (NL). This case study describes the foundational elements necessary for a real-world evidence generation project in NL and may provide learning for the effective execution of real-world studies in other jurisdictions. It uses an ongoing project in psoriatic disease in NL to illustrate the partnership and the benefits of RWE studies. Ultimately, the JANL-HIP RWE project aims to inform decisions that will drive improvements in health outcomes, system delivery, and policy mutually beneficial to health ecosystem stakeholders.

Similar Items